Featured
Status
Health Topics
Any Category-
- Animal Diseases 1
- Bacterial Infections and Mycoses 65
- Cardiovascular Diseases 92
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 125
- Digestive System Diseases 89
- Endocrine System Diseases 73
- Eye Diseases 16
- Female Urogenital Diseases and Pregnancy Complications 95
- Hemic and Lymphatic Diseases 117
- Immune System Diseases 126
- Male Urogenital Diseases 78
- Musculoskeletal Diseases 43
- Neoplasms 215
- Nervous System Diseases 147
- Nutritional and Metabolic Diseases 121
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 20
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 294
- Respiratory Tract Diseases 45
- Skin and Connective Tissue Diseases 40
- Stomatognathic Diseases 17
- Virus Diseases 68
- Wounds and Injuries 30
Search Clinical Trials
Completed
Confirmation of Ventilation and Intubation by Determination With Ultrasonography (External Link)
Endotracheal intubation is an important aspect of managing critically ill patients. Chest radiography remains the gold standard for confirming endotracheal tube positioning, however, ultrasonography can be a useful alternative. The …
Baylor Role:
Collaborator
Active, Not Recruiting
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study (External Link)
Spina bifida can be a devastating neurological congenital anomaly. It results from incomplete closure of the neural tube between 22 and 28 embryological days. Its incidence is approximately 1-2 per …
Baylor Role:
Lead Sponsor
Active, Not Recruiting
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) (External Link)
Approximately 18-30 subjects will participate in the treatment part of this study. Maximum of 180 mL of blood (not exceeding 3ml/kg/day) is collected from patients to grow the T cells …
Baylor Role:
Lead Sponsor
Terminated
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (External Link)
Avelumab is a fully human monoclonal PD-L1 antibody of the immunoglobulin G1 (IgG1) subclass. It works by binding to PD-L1 on tumor cells, immune cells and/or stromal cells. This prevents …
Baylor Role:
Lead Sponsor
Completed
Obesity-Related Glycine Deficiency: Investigating a Long-standing Metabolic Paradox Using Bedside and Bench Approaches (External Link)
Metabolic tracers: 1,2-[13C2]-Glycine, 1,2-[13C2]-Glycine, 2,3,3,-[2H3]-Serine and [2H5]-Phenylalanine will be infused for quantification of various pathways associated with glycine metabolism.
Baylor Role:
Collaborator
Withdrawn
Tranexamic Acid in Adherent Placenta (TAP) (External Link)
This trial is a randomized, double blind, placebo controlled trial to quantify the effects of the preoperative administration of tranexamic acid on estimated blood loss and blood product utilization in …
Baylor Role:
Lead Sponsor
Recruiting
Passive Dietary Intake Assessment Study (External Link)
This protocol describes the process of developing and validating a passive dietary monitoring system for the assessment of an individual's dietary intake in households in Ghana and Kenya. The first …
Baylor Role:
Collaborator
Completed
Pimavanserin Treatment in TS (External Link)
Tourette Syndrome is typically treated with drugs that block or reduce the function of dopamine (a brain chemical involved in movement). However, many of these drugs have adverse effects including …
Active, Not Recruiting
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging (External Link)
Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time, but continue to increase in diameter before they eventually rupture. Left …
Baylor Role:
Collaborator
Active, Not Recruiting
Effect of Early Range of Motion Following First Time Patellar Dislocation (External Link)
This study will look at two different ways to treat teen-age patients who have had a dislocation of their knee cap. Both groups will receive the physical therapy treatment for …
Baylor Role:
Lead Sponsor